2019 National Capacity Assessment Report

Total Page:16

File Type:pdf, Size:1020Kb

2019 National Capacity Assessment Report National Capacity Assessment Report Pursuant to CERCLA Section 104(c)(9) December 17, 2019 U.S. Environmental Protection Agency [Page intentionally left blank.] Acronyms Used in this Report BIFs Boilers and Industrial Furnaces BR Biennial Report or Hazardous Waste Report BTU British Thermal Unit CA Cooperative Agreement CAP Capacity Assurance Plan CERCLA Comprehensive Environmental Response, Compensation, and Liability Act CFR Code of Federal Regulations EPA U.S. Environmental Protection Agency EPA ID EPA Identification Number FR Federal Register GM Form Waste Generation and Management Form LQG Large Quantity Generator RCRA Resource Conservation and Recovery Act, as amended SARA 1986 Superfund Amendments and Reauthorization Act SQG Small Quantity Generator SSC State Superfund Contract TSDFs Treatment, Storage, and Disposal Facilities VSQG Very Small Quantity Generator WR Form Waste Received from Offsite Form [Page intentionally left blank.] Table of Contents Executive Summary .................................................................................................................. i 1. Introduction ................................................................................................................. 1 Background..................................................................................................................................... 1 Purpose and Organization of Report .............................................................................................. 3 2. Data Development ....................................................................................................... 3 Biennial Report Overview............................................................................................................... 4 Baseyear Data................................................................................................................................. 5 Baseline Data .................................................................................................................................. 8 Projection Data ............................................................................................................................... 8 3. Methodology Issues .................................................................................................... 9 Compilation of Permitted Operating Capacity Data .................................................................... 10 Demand from Hazardous Wastes Requiring Specialty Management .......................................... 10 Demand from Facilities Generating Small Amounts of Hazardous Wastes ................................. 10 Demand from Foreign Imports and Exports................................................................................. 11 Demand from Wastes that are Not RCRA Federally-Defined Hazardous Wastes ........................ 11 4. Discussion of the National Capacity Assessment ...................................................12 Aggregation of National Baseyear Data ....................................................................................... 12 National Assessment of Future Capacity ..................................................................................... 20 5. Conclusions ...............................................................................................................27 6. References .................................................................................................................29 Appendix A Commercial Hazardous Waste Management Facility Data ...............................31 Appendix B RCRA Federally-Defined Hazardous Waste Management Facilities .................41 Appendix C CAP Management Categories ...........................................................................133 Appendix D Methodology for Estimating Demand on Hazardous Waste Capacity ........... 145 Appendix E Hazardous Wastes Shipped to and Received from Foreign Countries (Hazardous Waste Exports and Imports) ..........................................................169 Appendix F 2017 Biennial Hazardous Waste Report Data Considerations ........................ 181 [Page intentionally left blank.] Executive Summary The need for Capacity Assurance is driven by Section 104(c)(9) of the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA), or Superfund law. The provision, enacted in the 1986 Superfund Amendments and Reauthorization Act (SARA), requires that, prior to the U.S. Environmental Protection Agency (EPA) providing funding for any remedial actions, a state must assure the availability of hazardous waste treatment or disposal facilities that have adequate capacity to manage the hazardous waste expected to be generated within the state over 20 years. The Congressional intent of this requirement is to assure that hazardous waste management capacity is available to avoid improper disposal and waste management issues. To help states fulfill this statutory requirement, a planning process was developed by a workgroup comprised of state, EPA, regulated industry, and environmental representatives. The planning process begins with EPA collecting data on waste treatment and disposal capacity, and the demand for this capacity nationwide. EPA refers to the Hazardous Waste Report (also known as the Biennial Report or BR), permit data in the RCRAInfo data system1, hazardous waste export data, and Internet research results. EPA also communicates directly with a limited number of the hazardous waste management facilities being examined to verify and supplement its data and estimates. EPA then compares the national hazardous waste treatment and disposal capacity to the demand for this capacity. EPA examines wastes managed onsite and shipped offsite for management at facilities under the same ownership (captive) and at commercial management facilities. The Agency’s 2019 assessment focuses on the nation’s capacity for energy recovery, incineration, and landfilling at commercial facilities because such facilities are often costly, difficult to permit, and are essential for managing much of the nation’s hazardous waste.2 The assessment indicates that there exists adequate capacity nationwide through December 31, 2044. Therefore, the assurance that there exists adequate capacity to manage 20 years of hazardous waste generation would expire on December 31, 2024. The statutory planning exercise to assess the capacity for the treatment and disposal of hazardous waste generated for the next 20 years goes well beyond the normal permitting periods, which are typically 5 to 10 years. The uncertainties of the permitting and permit renewal processes are inherent in any long-term projected needs for capacity. Because states typically permit the treatment and disposal facilities, and are also required to provide the CERCLA assurance to EPA, it is critical that states be engaged in the ongoing analysis of national capacity. EPA also believes that involvement by all stakeholders, including the public and the waste generation and management sectors, at both the national and state level is important regarding issues related to hazardous waste management practices and the development of hazardous waste management programs. For these reasons, EPA has provided the 2019 national capacity assessment, the analytical methodology, and data used in the analysis on EPA’s Capacity Assurance Planning web page to solicit comments for consideration in future capacity assessments. Documents used as the basis for the national capacity assessment are also posted on the web page. 1 RCRAInfo is a national database used by EPA to track entities regulated under Subtitle C of RCRA. 2 In recent years, several companies have chosen to shut down onsite waste management operations, so the commercial hazardous waste management industry is integral to many manufacturing and service sectors which rely on the ability of the commercial hazardous waste management sector to properly treat and dispose of wastes generated when producing products and providing important services here in the U.S. i [Page intentionally left blank.] ii 1. Introduction Background The Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA), or Superfund law, was amended by the Superfund Amendments and Reauthorization Act (SARA) on October 17, 1986. These amendments include the provisions under Section 104(c)(9) that require states to assure the availability of hazardous waste treatment or disposal facilities that have adequate capacity to manage the hazardous waste reasonably expected to be generated within the state over 20 years prior to the President providing funding for any remedial actions. The President delegated the authority to determine adequacy to the EPA Administrator. The capacity assurance requirement took effect three years after the enactment of SARA and must be provided in any State Superfund Contract (SSC) or Cooperative Agreement (CA) entered into between the state and EPA. Therefore, after October 17, 1989, no new Superfund remedial actions have been funded using federal remedial action resources without a state first entering into an agreement providing an assurance of capacity deemed adequate by EPA. CERCLA Section 104(c)(9) (9) Siting. Effective 3 years after the enactment of the Superfund Amendments and Reauthorization Act of 1986, the President shall not provide any remedial actions pursuant to this section unless the State in which the release occurs first enters into a contract or cooperative
Recommended publications
  • Non Confidential Version of Decision 08032010 for PUBLICATION Final
    COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 19.09.2007 C(2007) 4257 final COMMISSION DECISION of 19.09.2007 relating to a proceeding under Article 81 of the EC Treaty (Case COMP/E-1/39.168 – PO/Hard Haberdashery: Fasteners) (ONLY THE ENGLISH, FRENCH AND GERMAN TEXTS ARE AUTHENTIC) EN EN COMMISSION DECISION of 19.09.2007 relating to a proceeding under Article 81 of the EC Treaty (Case COMP/E-1/39.168 – PO/Hard Haberdashery: Fasteners) (Only the English, French and German texts are authentic) THE COMMISSION OF THE EUROPEAN COMMUNITIES, Having regard to the Treaty establishing the European Community, Having regard to Council Regulation (EC) No 1/2003 of 16 December 2002 on the implementation of the rules on competition laid down in Articles 81 and 82 of the Treaty1, and in particular Articles 7(1) and 23(2) thereof, Having regard to the Commission Decision of 17 September 2004 to initiate proceedings in this case, Having given the undertakings concerned the opportunity to make known their views on the objections raised pursuant to Article 27(1) of Regulation (EC) No 1/2003 and Article 12 of Commission Regulation (EC) No 773/2004 of 7 April 2004 relating to the conduct of proceedings by the Commission pursuant to Articles 81 and 82 of the EC Treaty2. After consulting the Advisory Committee on Restrictive Practices and Dominant Positions3, Having regard to the final report of the Hearing Officer in this case4 Whereas: PART I – FACTS 1. INTRODUCTION (1) This decision is addressed to the following undertakings and associations of undertakings: – A.
    [Show full text]
  • Tradebe Inutec: Innovative Solutions for Tritium
    Tradebe Inutec: Innovative Solutions for Tritium Tritium Handling Providing Customers with Tradebe Inutec is a leading provider of specialist radioactive waste Flexibility & Value Through: management services. We have successfully undertaken hundreds of projects to treat complex wastes on our secure site at Winfrith. • Dealing with LLW and Borderline ILW Waste Streams Tradebe Inutec’s Winfrith site is unique in terms of its technology, facilities • Taking Title to Wastes and and its radioactive discharge authorisations for Tritium decontamination and Reducing Risk disposal. • Delivering a Fast, Responsive We have developed innovative technology solutions for the treatment of most Service for Removing & tritium waste types, including desiccants and tritium storage beds (TSBs). Treating Wastes Tradebe Inutec has successfully treated large volumes of desiccant waste • Offering a Low-Risk & Cost from UK nuclear sites. We have disposed ILW desiccant as VLLW having Effective Alternative to removed a high proportion of the tritium as an aqueous waste and Customers Self-Performing. subsequently incinerating it. This is supported by in-house tritium measurement and analysis. We have in-house capabilities for tritium measurement by scintillation counting of liquid samples, on-line ionisation chamber measurement of gas and airborne tritium, radiographical measurement of tritium distribution over surfaces, mass spectrometry, and dedicated in-plant equipment associated with tritium recycling. Contact Details Chris Macey - 07775 996 234, [email protected] Tim Dowling - 07760 101 616, [email protected] David Ferguson - 07968 707 069, [email protected] W: www.tradebe.co.uk / www.inutec.co.uk Tradebe Inutec: Innovative Radioactive Waste Management Tradebe Inutec Tradebe Inutec provides innovative solutions across the waste management cycle and has established strong long-term relationships with all of the leading nuclear operators including Nuclear Power Utilities, Defence and Government organisations.
    [Show full text]
  • Grants a Permit to Tradebe Healthcare National Limited, Company
    COTTISH ENVIRONMENT PROTECTION AGENCY Pollution Prevention and Control Act 1999 Pollution Prevention and Control (Scotland) Regulations 2012 the Regulations") PERMIT TO OPERATE A `PART A' INSTALLATION Permit Number: PPC/ A/ 1180708 Operator: Tradebe Healthcare National Limited The Scottish Environment Protection Agency (" SEPA"), in accordance with the Regulations, hereby grants a permit to Tradebe Healthcare National Limited, company registration number 0388253 having its registered office at Atlas House, Third Avenue, Globe Park, Marlow, Buckinghamshire, SI -7 1 EY (" the Operator") to operate an installation on a site at Bellshill Healthcare Waste Treatment and Transfer Site, Building 2, 100 Inchinnan Road, Bellshill Industrial Estate, Bellshill, MI -4 3NT more particularly described in Schedule 1 of this permit, subject to the requirements of the Regulations and to the conditions contained in the Schedules to this Permit. Signed..........:..................... Date: 10 October 2019 Authorised to sign on behalf of the Scottish Environment Protection Agency Right of Appeal Under Regulation 58 of the Regulations you are entitled to appeal to the Scottish Ministers against any condition or conditions of this Permit within six months of the date of this Permit, except where SEPA has granted this Permit in implementation of a direction to SEPA of the Scottish Ministers. The bringing of an appeal will not have the effect of suspending the operation of the said condition or conditions. The procedures for the making of an appeal are set out in Schedule 8 of the Regulations. Scottish Environment Protection Age;icy THIS PAGE HAS BEEN INTENTIONALLY LEFT BLANK Scottish Environment Protection Agency Permit No: PPC/ A/ 1180708 CONTENTS INTERPRETATIONOF TERMS.....................................................................................................
    [Show full text]
  • Tradebe Healthcare National Ltd Bellshill Healthcare Waste
    Part A Permit Application or Variation Dec. Doc (Pt. 2) Form: IED-DD-02 V 1 Page no: 1 of 34 Tradebe Healthcare National Ltd Bellshill Healthcare Waste Treatment and Transfer Site Permit Application PPC/A/1180708 (Casefile ID - 19/31431) CONTENTS TRADEBE HEALTHCARE NATIONAL LTD............................................................................................1 BELLSHILL HEALTHCARE WASTE TREATMENT AND TRANSFER SITE ..........................................1 CONTENTS .............................................................................................................................................1 1 NON TECHNICAL SUMMARY OF DETERMINATION.................................................................3 2 EXTERNAL CONSULTATION AND SEPA’S RESPONSE ..........................................................5 3 ADMINISTRATIVE DETERMINATIONS.......................................................................................7 4 INTRODUCTION AND BACKGROUND .......................................................................................7 4.1 Historical Background to the activity and application .............................................................7 4.2 Description of activity.................................................................................................................7 4.3 Guidance/directions issued to SEPA by the Scottish Ministers under Reg.60 or 61. ............8 4.4 Identification of important and sensitive receptors..................................................................9 5
    [Show full text]
  • C-19-0617.Pdf
    C-19-0617 dƌĂĐŬŝŶŐEŽ͘ϭϵϬϳϬϬϳϲ &2175$&7'2&80(176 &,7<2)/,1&2/1/$1&$67(5&2817< 1(%5$6.$ $QQXDO6HUYLFHV +D]DUGRXV:DVWH6HUYLFHV 5)31R 7UDGHEH(QYLURQPHQWDO6HUYLFHV//& (UG$YH6XLWH 0HUULOOYLOOH,1 [ dƌĂĐŬŝŶŐEŽ͘ϭϵϬϳϬϬϳϲ &,7<2)/,1&2/1/$1&$67(5&2817<1(%5$6.$ &2175$&77(506 7+,6&2175$&7PDGHDQGHQWHUHGLQWRE\DQGEHWZHHQ7UDGHEH(QYLURQPHQWDO6HUYLFHV //&(UG$YH6XLWH0HUULOOYLOOH,1KHUHLQDIWHUFDOOHG³&RQWUDFWRU´DQGWKH&LW\ RI/LQFROQ1HEUDVNDDPXQLFLSDOFRUSRUDWLRQDQGWKH&RXQW\RI/DQFDVWHU1HEUDVNDDSROLWLFDO VXEGLYLVLRQRIWKH6WDWHRI1HEUDVNDKHUHLQDIWHUFDOOHGWKH³2ZQHUV´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
    [Show full text]
  • Tradebe Treatment & Recycling
    Charles D. Baker Matthew A. Beaton Governor Secretary Karyn E. Polito Martin Suuberg Lieutenant Governor Commissioner FACT SHEET Tradebe Treatment and Recycling of Stoughton, LLC 441R Canton Street Stoughton, MA 02072 EPA#MAD062179890 Hazardous Waste Facility License (renewal) This Fact Sheet summarizes the content of the Draft Hazardous Waste Facility License (Draft License) prepared by the Department of Environmental Protection (Department) for Tradebe Treatment and Recycling of Stoughton, LLC (Tradebe) pursuant to M.G.L. c. 21C and 310 CMR 30.000. This application is for a license renewal and no major changes to the license are being proposed. I. Purpose of the Licensing Process The purpose of the licensing process is to afford the Department, the U.S. Environmental Protection Agency (EPA), local government, and citizens the opportunity to evaluate the ability of a license applicant to comply with the applicable hazardous waste management regulations promulgated under M.G.L. c. 21C and 310 CMR 30.000. Facilities which treat, store and/or dispose of hazardous waste must be designed and safely operated to protect the people of Massachusetts from the dangers of improperly handled hazardous waste. Stringent licensing requirements are intended to ensure that those who accept hazardous waste are qualified to do so. Before issuance of any hazardous waste facility license, pursuant to M.G.L. c. 21C and 310 CMR 30.000, the Department is required to prepare a Draft License. The Draft License sets forth in one document all the applicable requirements that a licensee is required to comply with during the 5-year duration of the license.
    [Show full text]
  • Td897 75 M2b4 2013 14.Pdf
    MAINE STATE LEGISLATURE The following document is provided by the LAW AND LEGISLATIVE DIGITAL LIBRARY at the Maine State Law and Legislative Reference Library http://legislature.maine.gov/lawlib Reproduced from electronic originals (may include minor formatting differences from printed original) Report to the Joint Standing Committee on Environment and Natural Resources 12th Legislature, Second Session Biennial Hazardous Waste Activities Report November 2015 Contact: Leslie Anderson, Director, Bureau of Remediation and Waste Management Phone: (207) 287-7890 Maine Department of Environmental Protection Biennial Hazardous Waste Activities Report TABLE OF CONTENTS I. Executive Summary ......................................................................................................................2 II. Introduction ...................................................................................................................................2 III. Waste Generation ..........................................................................................................................3 IV. Waste Generation Trends ..............................................................................................................7 V. Licenses and Abbreviated Licenses ..............................................................................................8 VI. Import/Export Information .........................................................................................................8 VII. Maine Waste Handled at Commercial Hazardous
    [Show full text]
  • LIST of DISCLOSURES Last Name First Name Role Session Type
    LIST OF DISCLOSURES B. Research Grant (e.g. principal investigator, collaborator C. Other Research Support (e.g. receipt of drugs, supplies, D. Speakers Bureau/Honoraria (e.g. speakers bureau, E. Ownership Interest (e.g. stock options, patent or other Last Name First Name Role Session Type Session Title Day Start Time End Time A. Employment (full or part-time) or consultant and pending grants as well as grants already F. Consultant/Advisory Board (including volunteer roles) equipment or other in-kind support) symposia, and expert witness) intellectual property) received) Amit Mahajan Speaker Sessions in Co-operation Lung Surgery of the Future in co-operation with International Society for Minimally Monday 10 June 2019 16:00 17:00 Auris Robotics with other Societies Invasive Cardiothoracic Surgery (ISMICS) Arnaud Scherpereel Chair Sessions in Co-operation Mesothelioma Guidelines in co-operation with ERS/ESTRO/EACTS Tuesday 11 June 2019 15:00 16:00 BMS, Roche, Astra-Zeneca, MSD BMS, Roche, Astra-Zeneca, MSD with other Societies Arnaud Scherpereel Speaker Sessions in Co-operation Mesothelioma Guidelines in co-operation with ERS/ESTRO/EACTS Tuesday 11 June 2019 15:00 16:00 BMS, Astra-Zeneca, Roche, MSD BMS, Astra-Zeneca, Roche, MSD with other Societies Brendon Stiles Chair Educational Session ESTS Biology Club Sunday 9 June 2019 15:30 17:30 Pfizer, PPD AstraZeneca, Merck, Covidien, Lung Cancer Research Foundation Brendon Stiles Speaker Sessions in Co-operation ESTS-STS (Society of Thoracic Surgeons) Joint Session Tuesday 11 June 2019 15:00
    [Show full text]
  • Kevin M. Flannery
    Kevin M. Flannery Partner Philadelphia | Cira Centre, 2929 Arch Street, Philadelphia, PA, United States of America 19104- 2808 T +1 215 994 2814 | F +1 215 994 2222 [email protected] Services Intellectual Property > Patent Litigation > Hatch-Waxman Litigation > IP Litigation > Litigation > Trade Secrets and Unfair Competition > IP and Technology Licensing and Transactions > Life Sciences > Telecommunications, Media and Technology > Kevin M. Flannery is a nationally recognized trial lawyer who represents clients in complex patent and trade secret cases across a wide spectrum of technology areas. He has extensive experience acting as lead trial counsel in patent cases involving medical devices, pharmaceuticals, electronics, software and consumer products. Most recently, Mr. Flannery was co-counsel in a case before the U.S. Supreme Court on behalf of SCA Hygiene Products, where in a 7-1 decision, the Supreme Court overturned 100 years of precedent, concluding that laches cannot bar the award of legal damages in patent cases. Other successes include winning a US$22 million jury award in a patent case (settled favorably prior to appeal), a favorable pre-verdict settlement after a two-week jury trial in a trade secret case, and a US$4.6 million jury verdict in a patent infringement case, which was affirmed on appeal. Mr. Flannery also represents branded clients in litigation under the Hatch-Waxman Act. On behalf of Endo Pharmaceuticals, he was part of the trial team that prevailed in a five-week bench patent trial against seven manufacturers of generic drugs, winning injunctions against all seven and protecting Endo’s sales of its OPANA® ER tablets, which at its peak was the company’s second highest-selling product with US$300 million in annual sales.
    [Show full text]
  • AY2019 List of Major Employers (In Japanese Syllabary Order) Ritsumeikan Asia Pacific University, Career Office
    AY2019 List of Major Employers (in Japanese syllabary order) Ritsumeikan Asia Pacific University, Career Office Dom. Int. Company / Organization Dom. Int. Company / Organization Dom. Int. Company / Organization ○ ○ RGF Professional Recruitment Japan ○ JFE Shoji Trade Corporation○HAKUHODO DY MEDIA PARTNERS INCORPORATED ○ ○ IHI Corporation ○ JFE LOGISTICS CORPORATION ○ HAKUHODO PRODUCT'S INC. ○ Aoyama Seisakusho Co., Ltd. ○ JK Holdings Co., Ltd. ○ Pasona Inc. ○ Akachan Honpo Co.,Ltd. ○ JTB Global Marketing & Travel Inc. ○ Pasona Group Inc. ○ ○ Accenture Japan Ltd ○ JTB Pte Ltd. ○ BANDAI NAMCO Entertainment Inc. ○ AsiaQuest Inc. ○ JTEKT CORPORATION ○ East Japan Railway Company ○ Ashimori Industry Co., Ltd. ○ J Trust Co.,Ltd. ○ HITACHI CHEMICAL CO., LTD. ○ Azbil Corporation ○ Citizen Watch Co., Ltd. ○ Hitachi High-Tech Solutions Corporation ○ Apple Japan GK ○ SHIMADZU CORPORATION ○ Hilton Tokyo ○ Adecco Ltd. ○ JAL SKY CO.,LTD. ○ Hilton NISEKO VILLAGE ○ Adways Inc. ○ JALSKY Kyushu Co.,Ltd. ○ FAST RETAILING CO., LTD. ○ ADVANTEC CO., LTD. ○ Singapore Airlines. ○ Foster Electric Company, Limited ○ ANABUKI KOSAN INC. ○ Swissotel Nankai Osaka ○ ○ THE BANK OF FUKUOKA, LTD. ○ APA GROUP ○ Skymark Airlines Inc. ○ THE FUKUOKA CHUO BANK, LTD. ○ Amano Enzyme Inc. ○ SUZUYO & CO., LTD. ○ Fuji Xerox Co., Ltd. ○ ULVAC, Inc. ○ State Street Trust and Banking Company, Ltd. ○ ○ FUJITSU LIMITED ○ Allegis Group Japan KK ○ Striders Corporation ○ FUJITSU FRONTECH LIMITED ○ Anchor Business Consulting Inc. ○ Sumisho Global Logistics Co., Ltd. ○ Fujitsu Marketing Limited ○ ANZEN MOTOR CAR CO.,LTD. ○ SUMITOMO DENSETSU CO.,LTD. ○ PLUS CORPORATION ○ AEON MALL Co., Ltd. ○ salesforce.com, inc. ○ ○ Freewill ○ Ishida Co., Ltd. ○ SEPTENI HOLDINGS CO.,LTD. ○ British American Tobacco Japan ○ IZUMI Co.,Ltd. ○ Seven-Eleven Japan Co.,Ltd. ○ Bloomberg L.P. ○ IDOM INC. ○ SENKO Co., Ltd. ○ The Howa Bank, Ltd.
    [Show full text]
  • Annual Report
    ANNUAL REPORT 2019 MARCH 2020 To Our Shareholders Alex Gorsky Chairman and Chief Executive Officer By just about every measure, Johnson & These are some of the many financial and Johnson’s 133rd year was extraordinary. strategic achievements that were made possible by the commitment of our more than • We delivered strong operational revenue and 132,000 Johnson & Johnson colleagues, who adjusted operational earnings growth* that passionately lead the way in improving the health exceeded the financial performance goals we and well-being of people around the world. set for the Company at the start of 2019. • We again made record investments in research and development (R&D)—more than $11 billion across our Pharmaceutical, Medical Devices Propelled by our people, products, and and Consumer businesses—as we maintained a purpose, we look forward to the future relentless pursuit of innovation to develop vital with great confidence and optimism scientific breakthroughs. as we remain committed to leading • We proudly launched new transformational across the spectrum of healthcare. medicines for untreated and treatment-resistant diseases, while gaining approvals for new uses of many of our medicines already in the market. Through proactive leadership across our enterprise, we navigated a constant surge • We deployed approximately $7 billion, of unique and complex challenges, spanning primarily in transactions that fortify our dynamic global issues, shifting political commitment to digital surgery for a more climates, industry and competitive headwinds, personalized and elevated standard of and an ongoing litigious environment. healthcare, and that enhance our position in consumer skin health. As we have experienced for 133 years, we • And our teams around the world continued can be sure that 2020 will present a new set of working to address pressing public health opportunities and challenges.
    [Show full text]
  • Page 1 Vendors Shall Submit Prices for Recycling, Disposal, Or Treatment Methods Listed for Each Waste Quantity. If Vendors Have
    COST PROPOSAL page 1 Vendors shall submit prices for recycling, disposal, or treatment methods listed for each waste quantity. If vendors have different quantity containers, they may list these and also provide pricing for these containers. Vendors may provide their costs in another format so long as all requested information is included. Pricing per container to be inclusive of vendor providing all personnel, equipment, containers, vehicles, and other materials to provide for service. No extraneous fees (mobilization, per diem, etc.). All invoices are to be billed as prices per containers picked up and shall include all necessary costs. Price per individual (unit) Quantity (If quantity not given, vendor shall specify their quantity) A) Bulk Waste Streams Type Quantity Cost Disposal 1 Bulk Halogenated 55 gal $129.38 Fuel Blend 2 Bulk Non-Halogenated* 55 gal $74.52 Fuel Blend 3 Paint Waste 55 gal $108.68 Fuel Blend 4 Ink Waste 55 gal $98.33 Fuel Blend 5 Lab Wastes 55 gal $175.95 Treatment 6 Bulk Corrosive Liquids 55 gal $175.95 Treatment 7 Filter Waste 55 gal $155.25 Recycle 8 Mud Pit Wastes 55 gal $112.82 Treatment 9 Bulk Solids or Liquids (HAZ) 55 gal $263.93 Stabilization/Landfill 9.1 Bulk Solids or Liquids (nonhaz) 55 gal $87.98 Stabilization/Landfill 10 Spent Peroxymonosulfuric Acid** 30 gal $439.88 Incineration 11 Spent Photo Fixer 55 gal $112.82 Stabilization/Landfill 12 Bulk Used Silica Gel (D Codes) 55 gal $143.87 Stabilization/Landfill *Bulk Non-Halogenated: >5,000 BTU's and <5% Chloride ** $2.90 per lb for drums weighing more than 160 per lbs <8% Hydrogen Peroxide, <8% sulfuric, nitric acid, >60% water Secure Other- Quantity Landfill Incineration Treatment Specify*** B) Lab Packs 1.
    [Show full text]